BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Boston Biomedical Appoints Edgar Braendle, M.D., Ph.D., as Head of Research and Development and Chief Medical Officer

  Boston Biomedical today announced the appointment of Edgar Braendle, M.D., Ph.D., to Executive VP, Head of Research and Development and CMO.

  October 16, 2017

   · 

  4 min read
• Business

  Applied BioMath, LLC announces collaboration with Sanofi for quantitative systems pharmacology modeling in immuno-oncology

  Applied BioMath today announced a collaboration with Sanofi to develop QSP models in immuno-oncology.

  October 16, 2017

   · 

  2 min read
• Business

  Lilly Declares Fourth-Quarter 2017 Dividend

  The board of directors of Eli Lilly has declared a dividend for the fourth quarter of 2017 of $0.52 per share on outstanding common stock.

  October 16, 2017

   · 

  1 min read
• Biotech Bay

  IGeneX Inc. Introduces New Diagnostic Tests for Lyme Disease and Tick-Borne Relapsing Fever

  IGeneX Inc. announce the launch of three new tests that are more inclusive and specific for aiding in diagnosis of Borreliosis (Lyme Disease and Tick-Borne Relapsing Fever, Borreliosis).

  October 16, 2017

   · 

  3 min read
• Business

  T2 Biosystems Announces 2017 Third Quarter Financial and Operational Results Release and Conference Call Date

  T2 Biosystems will release its 2017 third quarter financial and operational results after the market closes on Thursday, November 2, 2017.

  October 16, 2017

   · 

  2 min read
• BioMidwest

  Abeona Announces $13.85M Grant from Leading Sanfilippo Syndrome Foundations for Clinical Development of MPS III Gene Therapies

  Nine global foundations collaborate to grant $13.85 million for the continued advancement of lead Sanfilippo gene therapy programs.

  October 16, 2017

   · 

  4 min read
• Drug Development

  Innate Pharma: IPH4102 - Final Results of the Dose-Escalation Part of the Phase I Study

  Innate Pharma announces that final results of the dose-escalation part of the ongoing Phase I study investigating IPH4102 in patients with relapsed/refractory cutaneous T-cell lymphomas.

  October 16, 2017

   · 

  6 min read
• Deals

  Week In Review: Shanghai Pharma Bids In Cardinal China’s $1.5 Billion Auction

  Shanghai Pharma and FountainVest Partners, a China PE fund, submitted second-round bids for Cardinal China’s $1.5 billion drug distribution operations.

  October 16, 2017

   · 

  1 min read
• Business

  Cerveau Technologies Signs Collaboration Agreement With Janssen For Novel Tau Imaging Agent

  Cerveau Technologies today announced a research collaboration agreement with Janssen Pharmaceuticals, Inc. for use of [F-18]MK-6240.

  October 16, 2017

   · 

  1 min read
• Orthocell Granted Celgro Patent Protection In Canada

  Regenerative medicine company Orthocell Limited is pleased to announce it has been granted a Canadian patent for its CelGro collagen medical device platform for soft tissue regeneration and repair applications.

  October 16, 2017

   · 

  3 min read